Explanatory statement

• Replacement date: 16 February 2022

  Replacement type: Rectification

  Reason: To address concerns raised by the Senate Standing Committee for the Scrutiny of Delegated Legislation
  • Therapeutic Goods (Standard for Human Cell and Tissue Products—Donor Screening Requirements) (TGO 108) Order 2021.docx
    74 KB
    23 pages
  • Therapeutic Goods (Standard for Human Cell and Tissue Products—Donor Screening Requirements) (TGO 108) Order 2021.pdf
    771 KB
    26 pages
  • Therapeutic Goods (Standard for Human Cell and Tissue Products—Donor Screening Requirements) (TGO 108) Order 2021.epub
    20 KB
    23 pages
• Replacement date: 28 September 2021

  Replacement type: Rectification

  Reason: Amendments made in response to scrutiny concerns raised by the Senate Scrutiny Committee for Delegated Legislation in relation to TGO 108 and TGO 109.
  • Therapeutic Goods (Standard for Human Cell and Tissue Products—Donor Screening Requirements) (TGO 108) Order 2021.docx
    68 KB
    23 pages
  • Therapeutic Goods (Standard for Human Cell and Tissue Products—Donor Screening Requirements) (TGO 108) Order 2021.pdf
    739 KB
    23 pages
  • Therapeutic Goods (Standard for Human Cell and Tissue Products—Donor Screening Requirements) (TGO 108) Order 2021.epub
    17 KB
    23 pages